Get started
10X GENOMICS INC10X GENOMICS INC10X GENOMICS INC

10X GENOMICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

TXG chart


Full chart

TXG upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪20.67 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−26.54 MXN
Net income (FY)
‪−3.81 B‬ MXN
Revenue (FY)
‪12.73 B‬ MXN
Shares float
‪103.44 M‬
Beta (1Y)
1.29

Employees


Employees (FY)
‪1.31 K‬
Change (1Y)
+47 +3.73%
Revenue / Employee (1Y)
‪9.75 M‬ MXN
Net income / Employee (1Y)
‪−2.92 M‬ MXN

About 10x Genomics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Serge Saxonov
Website
10xgenomics.com
Headquarters
Pleasanton
Founded
2012
FIGI
BBG00Z6QRNY1
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TXG news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as TXG.

Frequently Asked Questions


The current price of TXG is 150.00 MXN — it has decreased by −65.91% in the past 24 hours. Watch 10X GENOMICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange 10X GENOMICS INC stocks are traded under the ticker TXG.
We've gathered analysts' opinions on 10X GENOMICS INC future price: according to them, TXG price has a max estimate of 347.94 MXN and a min estimate of 125.65 MXN. Watch TXG chart and read a more detailed 10X GENOMICS INC stock forecast: see what analysts think of 10X GENOMICS INC and suggest that you do with its stocks.
TXG reached its all-time high on Apr 29, 2021 with the price of 3,938.72 MXN, and its all-time low was 150.00 MXN and was reached on Apr 4, 2025. View more price dynamics on TXG chart.
See other stocks reaching their highest and lowest prices.
TXG stock is 193.33% volatile and has beta coefficient of 1.29. Track 10X GENOMICS INC stock price on the chart and check out the list of the most volatile stocks — is 10X GENOMICS INC there?
Today 10X GENOMICS INC has the market capitalization of ‪21.49 B‬, it has decreased by −14.73% over the last week.
Yes, you can track 10X GENOMICS INC financials in yearly and quarterly reports right on TradingView.
10X GENOMICS INC is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
TXG earnings for the last quarter are −5.74 MXN per share, whereas the estimation was −9.58 MXN resulting in a 40.09% surprise. The estimated earnings for the next quarter are −7.09 MXN per share. See more details about 10X GENOMICS INC earnings.
10X GENOMICS INC revenue for the last quarter amounts to ‪3.17 B‬ MXN, despite the estimated figure of ‪2.73 B‬ MXN. In the next quarter, revenue is expected to reach ‪2.71 B‬ MXN.
TXG net income for the last quarter is ‪−703.90 M‬ MXN, while the quarter before that showed ‪−1.02 B‬ MXN of net income which accounts for 31.14% change. Track more 10X GENOMICS INC financial stats to get the full picture.
No, TXG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has ‪1.31 K‬ employees. See our rating of the largest employees — is 10X GENOMICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 10X GENOMICS INC EBITDA is ‪−2.85 B‬ MXN, and current EBITDA margin is −24.31%. See more stats in 10X GENOMICS INC financial statements.
Like other stocks, TXG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 10X GENOMICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 10X GENOMICS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 10X GENOMICS INC stock shows the sell signal. See more of 10X GENOMICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.